Debut Plus

₹239.3

■ +0 +0.00%

17 Jul 2026

BSE Listed · Pharmaceuticals

Medicamen Biotech Ltd. (531146)

Volume: 0Avg Vol 1W: 1,231Avg Vol 1M: 3,91252W Range:₹216₹454
BSE www.medicamen.com
Key Ratios
Checked just now
Market Cap₹325 Cr
Current Price₹239.3
Previous Close₹239.3
High / Low (52w)₹454 / ₹216
Volume0
Avg Vol (1W)1,231
Avg Vol (1M)3,912
Stock P/E33.66
Book Value₹203.17
Dividend Yield42%
ROE349.89%
ROA263.18%
Revenue (TTM)—
Revenue Growth-9.35%
Profit Margin5.5%
Total Debt₹4 Cr
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹7.11
P/B1.18
Debt / Equity0.15
50 DMA₹252.64
200 DMA₹312.68
Day change+0.00%
Price Chart
₹239.3▼ 41.98% · 1Y
₹476₹22424K
2025-07-17
2026-07-17

20-day avg volume: 4K shares

Pros
  • Healthy return on equity of 349.9%.
  • Pays a dividend yield of 42.0%.
  • Company is almost debt-free.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹43 Cr₹45 Cr₹45 Cr₹30 Cr₹43 Cr₹47 Cr₹47 Cr₹61 Cr
EBITDA₹2 Cr₹3 Cr₹5 Cr₹3 Cr₹3 Cr₹4 Cr₹3 Cr₹5 Cr
Net Profit₹1 Cr₹1 Cr₹3 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr₹4 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹126 Cr₹127 Cr₹113 Cr₹117 Cr₹143 Cr₹182 Cr₹169 Cr
EBITDA₹18 Cr₹19 Cr₹17 Cr₹19 Cr₹20 Cr₹17 Cr₹13 Cr
Net Profit₹12 Cr₹13 Cr₹12 Cr₹15 Cr₹15 Cr₹11 Cr₹7 Cr
EPS10.2810.949.9312.1911.648.635.6
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹137 Cr₹181 Cr₹194 Cr₹226 Cr₹279 Cr₹295 Cr₹297 Cr
Total Liabilities₹50 Cr₹60 Cr₹61 Cr₹79 Cr₹85 Cr₹88 Cr₹84 Cr
Equity₹87 Cr₹121 Cr₹133 Cr₹146 Cr₹193 Cr₹207 Cr₹213 Cr
Total Debt———————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹8 Cr₹17 Cr₹17 Cr₹7 Cr₹-3 Cr₹-4 Cr₹-7 Cr
Investing₹-15 Cr₹-37 Cr₹-18 Cr₹-8 Cr₹-6 Cr₹-6 Cr₹-1 Cr
Financing₹-4 Cr₹19 Cr₹6 Cr₹4 Cr₹29 Cr₹6 Cr₹-1 Cr
Free Cash Flow₹8 Cr₹17 Cr₹17 Cr₹7 Cr₹-3 Cr₹-4 Cr₹-7 Cr
Shareholding
Promoter 40.46% Institutions 0.1% Public 59.45%
Efficiency & Working Capital
ROCE4.8%
Interest Coverage3.7
Dividend Payout—
Debtor Days155 d
Inventory Days140 d
Payable Days96 d
Cash Conversion Cycle198 d
Working Capital Days294 d
Shareholding Details

As of 2026-03-31

Promoter40.5%
FII0.1%
DII0%
Institutions0.1%
Public59.4%
Promoter Pledge0%
No. of Shareholders10,806
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Apr 2025Apr 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters43.2%43.2%43%43%43%43.2%40.5%40.5%40.5%40.5%40.5%40.5%
FIIs0.2%0.1%0.1%0.1%0.1%0.1%0.2%0.2%0%0.1%0%0.1%
DIIs0.7%1%1.2%1.2%0.9%0.7%0.6%0.6%0.6%0.6%0.4%0%
Public55.9%55.7%55.8%55.8%56.1%56%58.6%58.7%58.9%58.9%59.1%59.4%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders10,25210,63910,65210,79210,57610,43510,59210,59210,80811,17710,96710,806
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Shivalik Rasayan LimitedShareholding of Promoter and Promoter Group40.5%54,87,095
Pharmadanica A/sPublic Shareholding9.9%13,40,000
Veralogix Holdings(pty) LtdPublic Shareholding4.4%5,99,995
Ginnerup Capital ApsPublic Shareholding2.6%3,54,820
Ritesh Kantilal OswalPublic Shareholding1.2%1,55,612
Rajesh MadanPublic Shareholding1.1%1,54,000
Vijay Amichand SanghviPublic Shareholding1.1%1,50,000
Growel Remedies LimitedShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Shivalik Rasayan Limited00%2026-03-31
Growel Remedies Limited00%2026-03-31
Rajesh Madan00%2026-03-31
Ritesh Kantilal Oswal00%2026-03-31
Vijay Amichand Sanghvi00%2026-03-31
Pharmadanica A/s00%2026-03-31
Veralogix Holdings(pty) Ltd00%2026-03-31
Ginnerup Capital Aps00%2026-03-31
Shivalik Rasayan Limited00%2025-12-31
Growel Remedies Limited00%2025-12-31
Rajesh Madan00%2025-12-31
Ritesh Kantilal Oswal00%2025-12-31
Board of Directors
NameDesignationYear
Rahul BishnoiChairman & Non Executive Dir.2025
Vimal Kumar ShrawatNon-Exec & Non-Independent Dir2025
S K SinghNon-Exec & Non-Independent Dir2025
Ashwani Kumar SharmaNon-Exec & Non-Independent Dir2025
Sanjay BansalNon-Exec & Non-Independent Dir2025
Harish PandeIndependent Non Exe. Director2025
Arun KumarIndependent Non Exe. Director2025
Sumita DwivediIndependent Non Exe. Director2025
Sangeeta BishnoiIndependent Non Exe. Director2025
Ravi Kumar BansalIndependent Non Exe. Director2025
SHAM GOELIndependent Non Exe. Director2025
SHAIVAL SAURABHIndependent Non Exe. Director2025
Parul ChoudharyCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Pharmaceuticals₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10151313
Corporate Actions
TypeDateValueRemark
dividend2025-09-19₹1 (10%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025100108
2025000107
2025100001
Insider / Designated-Person Trades

28 recent disclosure(s)

Sanjay BansalDisposal · 1,00,000
Shivalik Rasayan LimitedAcquisition · 21,000
Shivalik Rasayan LimitedAcquisition · 21,000
Geetika MadanDisposal · 2,000
Geetika MadanDisposal · 313
Geetika MadanDisposal · 3,000
Substantial Acquisitions (SAST)

2 disclosure(s)

Market22/03/2024 · 2,00,000
Market31/12/2021 · 24,990
Company Information
Incorporated1993
ChairmanRahul Bishnoi
AuditorRai Qimat & Associates
Investor Email[email protected]
🌐 www.medicamen.com ↗

📍 1506 Chiranjiv Tower 43, Nehru Place, New Delhi, New Delhi, 110019

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Ceenik Exports (India) Ltd.Kati Patang Lifestyle LimitedMena Mani Industries LimitedInani Marbles & IndustrieGemstone Investments Ltd.EL Forge Ltd.Diligent Industries Ltd.Epsom Properties Ltd.Alfavision Overseas (IndiOrganic Coatings Ltd.Catvision LimitedEmamiAll “53” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search